ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
1.980
+0.500 (33.78%)
At close: Jul 14, 2025, 4:00 PM
1.990
+0.010 (0.51%)
After-hours: Jul 14, 2025, 4:23 PM EDT
ImmunoPrecise Antibodies Market Cap
ImmunoPrecise Antibodies has a market cap or net worth of $90.61 million as of July 14, 2025. Its market cap has increased by 244.54% in one year.
Market Cap
90.61M
Enterprise Value
86.51M
1-Year Change
244.54%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since December 31, 2020, ImmunoPrecise Antibodies's market cap has decreased from $250.60M to $90.61M, a decrease of -63.84%. That is a compound annual growth rate of -20.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 48.60M | 333.93% |
| Dec 31, 2024 | 11.20M | -73.83% |
| Dec 29, 2023 | 42.80M | -67.05% |
| Dec 30, 2022 | 129.90M | 25.14% |
| Dec 31, 2021 | 103.80M | -58.58% |
| Dec 31, 2020 | 250.60M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.60B |
| Johnson & Johnson | 377.32B |
| AbbVie | 338.30B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 272.67B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 229.71B |
| AstraZeneca | 218.74B |